Individualised controlled ovarian stimulation (iCOS): maximising success rates for assisted reproductive technology patients
Open Access
- 1 January 2011
- journal article
- research article
- Published by Springer Nature in Reproductive Biology and Endocrinology
- Vol. 9 (1) , 82
Abstract
In the last two decades, pregnancy rates for patients undergoing in-vitro fertilisation (IVF) have significantly increased. Some of the major advances responsible for this improvement were the introduction of controlled ovarian stimulation (COS) for the induction of multiple follicle development, and the utilisation of mid-luteal gonadotropin-releasing hormone agonists to achieve pituitary down-regulation and full control of the cycle. As a result, a combination of a gonadotropin-releasing hormone agonist with high doses (150-450 IU/day) of recombinant follicle-stimulating hormone has become the current standard approach for ovarian stimulation. However, given the heterogeneity of patients embarking on IVF, and the fact that many different drugs can be used alone or in different combinations (generating multiple potential protocols of controlled ovarian stimulation), we consider the need to identify special populations of patients and adapt treatment protocols accordingly, and to implement a more individualised approach to COS.Keywords
This publication has 81 references indexed in Scilit:
- The effect of transdermal testosterone gel pretreatment on controlled ovarian stimulation and IVF outcome in low respondersFertility and Sterility, 2011
- Identification andin VitroCharacterization of Follicle Stimulating Hormone (FSH) Receptor Variants Associated with Abnormal Ovarian Response to FSHThe Journal of Clinical Endocrinology & Metabolism, 2010
- Poor Prognosis with In Vitro Fertilization in Indian Women Compared to Caucasian Women Despite Similar Embryo QualityPLOS ONE, 2009
- Impact of female age and male infertility on ovarian reserve markers to predict outcome of assisted reproduction technology cyclesReproductive Biology and Endocrinology, 2009
- Follicular fluid content and oocyte quality: from single biochemical markers to metabolomicsReproductive Biology and Endocrinology, 2009
- FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programsJournal of Assisted Reproduction and Genetics, 2006
- A comparison of three downregulation approaches for poor responders undergoing in vitro fertilizationFertility and Sterility, 2005
- The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: A pilot studyFertility and Sterility, 2005
- Functional characterization of a natural variant of luteinizing hormoneHuman Genetics, 2002
- Pregnancies in Humans by Fertilization in Vitro and Embryo Transfer in the Controlled Ovulatory CycleScience, 1981